Recent Quarter Total Invested
$364.97 M
Recent Quarter Institutional Ownership Percentage
91.96%
Total Invested of Last Quarter
$281.20 M
Ownership Percentage of Last Quarter
88.45%
C4 Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| LYNX1 CAPITAL MANAGEMENT LP | 11/14/2024 | 6.88 M | $39.22 B | 0.00% | 9.88% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 11/14/2024 | 6.60 M | $37.64 M | 62.98% | 9.48% |
| WASATCH ADVISORS LP | 11/14/2024 | 5.68 M | $32.36 M | 17.13% | 8.15% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 4.89 M | $27.88 M | 100.00% | 7.02% |
| RA CAPITAL MANAGEMENT, L.P. | 11/14/2024 | 4.88 M | $27.80 M | 0.00% | 7.01% |
| ORBIMED ADVISORS LLC | 11/14/2024 | 4.38 M | $24.95 M | 189.34% | 6.29% |
| COMMODORE CAPITAL LP | 11/14/2024 | 3.41 M | $19.44 M | 0.00% | 4.90% |
| STATE STREET CORP | 11/14/2024 | 2.81 M | $16.00 M | -6.28% | 4.03% |
| MORGAN STANLEY | 11/14/2024 | 2.33 M | $13.26 M | 104.42% | 3.34% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 2.04 M | $11.61 M | 15.14% | 2.92% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.37 M | $7.81 M | 0.55% | 1.97% |
| ARROWMARK COLORADO HOLDINGS LLC | 11/14/2024 | 1.32 M | $7.52 M | 6.04% | 1.90% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2024 | 1.20 M | $6.85 M | 331.42% | 1.73% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 11/14/2024 | 1.15 M | $6.54 M | -20.44% | 1.65% |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 11/14/2024 | 1.11 M | $6.34 M | 0.00% | 1.60% |
| TWO SIGMA ADVISERS, LP | 11/14/2024 | 1.07 M | $6.07 M | -23.45% | 1.53% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 828,490 | $4.72 M | -36.65% | 1.19% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2024 | 700,000 | $3.99 M | 250.00% | 1.01% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 578,885 | $3.30 M | -6.50% | 0.83% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2024 | 520,000 | $2.96 M | 100.00% | 0.75% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 505,852 | $2.88 M | -31.44% | 0.73% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 482,929 | $2.75 M | -1.23% | 0.69% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 392,004 | $2.24 M | 529.15% | 0.56% |
| UBS GROUP AG | 11/14/2024 | 334,081 | $1.90 M | -17.33% | 0.48% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 286,041 | $1.63 M | 24.72% | 0.41% |
| TREXQUANT INVESTMENT LP | 11/12/2024 | 266,159 | $1.52 M | 124.66% | 0.38% |
| BARCLAYS PLC | 11/19/2024 | 243,457 | $1.39 M | 38.40% | 0.35% |
| MARSHALL WACE, LLP | 11/14/2024 | 225,416 | $1.28 M | 100.00% | 0.32% |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 10/22/2024 | 192,364 | $1.10 M | 34.68% | 0.28% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 187,600 | $1.07 M | -28.10% | 0.27% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 180,853 | $1.03 M | -58.04% | 0.26% |
| ORBIMED ADVISORS LLC | 11/14/2024 | 150,000 | $855,000 | 100.00% | 0.22% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 11/14/2024 | 150,000 | $855,000 | 100.00% | 0.22% |
| SQUAREPOINT OPS LLC | 11/14/2024 | 147,874 | $842,882 | 158.90% | 0.21% |
| RAFFERTY ASSET MANAGEMENT, LLC | 11/13/2024 | 143,855 | $819,974 | -22.55% | 0.21% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 143,293 | $816,773 | -24.88% | 0.21% |
| JUMP FINANCIAL, LLC | 11/14/2024 | 134,636 | $767,425 | -39.68% | 0.19% |
| MARINER, LLC | 11/13/2024 | 130,411 | $743,343 | 1.98% | 0.19% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2024 | 122,373 | $697,526 | 11.17% | 0.18% |
| D. E. SHAW & CO., INC. | 11/14/2024 | 118,892 | $677,684 | -66.62% | 0.17% |
| M&T BANK CORP | 11/19/2024 | 113,907 | $649,407 | 19.35% | 0.16% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 11/14/2024 | 103,026 | $587,250 | -81.63% | 0.15% |
| RHUMBLINE ADVISERS | 11/12/2024 | 95,649 | $545,195 | 5.55% | 0.14% |
| CITADEL ADVISORS LLC | 11/14/2024 | 85,100 | $485,070 | 74.03% | 0.12% |
| VIENNA POWSZECHNE TOWARZYSTWO EMERYTALNE S.A. VIENNA INSURANCE GROUP | 11/07/2024 | 85,000 | $484,500 | 0.00% | 0.12% |
| XTX TOPCO LTD | 11/14/2024 | 84,951 | $484,221 | 100.00% | 0.12% |
| SIMPLEX TRADING, LLC | 11/08/2024 | 80,499 | $458,000 | 91.20% | 0.12% |
| ARETE WEALTH ADVISORS, LLC | 11/18/2024 | 73,350 | $418,000 | -34.10% | 0.11% |
| INVESCO LTD. | 11/12/2024 | 64,546 | $367,912 | -1.46% | 0.09% |
| LPL FINANCIAL LLC | 11/08/2024 | 62,175 | $354,398 | 181.33% | 0.09% |
C4 Therapeutics, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of CCCC shares?
During the previous two years, 140 institutional investors and hedge funds held shares of C4 Therapeutics, Inc.. The most heavily invested institutionals were:
Lynx1 Capital Management LP: 6.88 M
Soleus Capital Management, L.P.: 6.6 M
WASATCH ADVISORS LP: 5.68 M
BlackRock Funding, Inc. /DE: 4.89 M
RA CAPITAL MANAGEMENT, L.P.: 4.88 M
ORBIMED ADVISORS LLC: 4.38 M
-
What percentage of C4 Therapeutics, Inc. stock is owned by institutional investors?
91.96% of C4 Therapeutics, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at CCCC ?
Institutional investors have bought a total of 65.23 M shares in the last 24 months. This purchase volume represents approximately $261.59 M in transactions.